Genomic Profiling Systems

Rapid Micro Biosystems, formerly known as Genomic Profiling Systems, is a life sciences technology company that provides automated microbial quality control (MQC) solutions for the pharmaceutical and biotech industries. The company's flagship Growth Direct platform automates the detection and quantification of microbial contamination in manufacturing processes, replacing traditional manual methods that are slow and prone to error. By providing faster results and reducing the risk of contamination, the technology helps manufacturers of biologics, vaccines, and cell therapies accelerate production and ensure product safety. The system utilizes digital imaging and autofluorescence to detect growing microbial colonies days faster than the human eye. Headquartered in Lowell, Massachusetts, the company is publicly traded on the NASDAQ under the symbol RPID.